Quality of life and disease severity are correlated in children with atopic dermatitis
about
Psychological and educational interventions for atopic eczema in childrenPsychological and educational interventions for atopic eczema in childrenParents' reported preference scores for childhood atopic dermatitis disease statesHealth outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trialEvaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients.Alpine climate treatment of atopic dermatitis: a systematic review.Child Allergic Symptoms and Well-Being at School: Findings from ALSPAC, a UK Cohort Study.Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomised trialComorbidity in Atopic Dermatitis.Exceeding the recruitment target in a primary care paediatric trial: an evaluation of the Choice of Moisturiser for Eczema Treatment (COMET) feasibility randomised controlled trial.Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).Role of food allergy in childhood atopic dermatitis.Evaluation of the child with atopic dermatitis.Anti-allergic drug discovery in China for eczema: current methods and future strategies.Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.Factors contributing to poor treatment outcomes in childhood atopic dermatitis.Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)Conceptualisation, development and validation of T-QoL© (Teenagers' Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases.Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis.Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence.The effect of a Web-based education programme (WBEP) on disease severity, quality of life and mothers' self-efficacy in children with atopic dermatitis.Quality of life and disease severity in patients with atopic dermatitis.Parental knowledge, attitude, and behavior toward children with atopic dermatitis.Attitudes of Australian dermatologists to the use and safety of topical corticosteroids in paediatric atopic dermatitis.Exploring Staphylococcus epidermidis in atopic eczema: friend or foe?Educational background of nurses and their perceptions of the quality and safety of patient care.Clinical features and Staphylococcus aureus colonization/infection in childhood atopic dermatitis.Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education.Overexpression of AQP3 and AQP10 in the skin exacerbates psoriasiform acanthosisEffect of standard medication on quality of life of patients with atopic dermatitis.IMPACT OF ATOPIC DERMATITIS ON THE QUALITY OF LIFE OF PEDIATRIC PATIENTS AND THEIR GUARDIANS.A comparative study of the Children's Dermatology Life Quality Index (CDLQI) in paediatric dermatology clinics in the UK and Bulgaria.Quality of life in children and teenagers with atopic dermatitis.Therapeutic benefits of natural ingredients for atopic dermatitis.The Economics Burden of Atopic Dermatitis.Atopic dermatitis characteristics and medication-use patterns in school-age children with AD and asthma symptoms.Economic assessment of actual prescription of drugs for treatment of atopic dermatitis: Differences between dermatology and pediatrics in large-scale receipt data.Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) Task Force on quality of life.Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial).
P2860
Q24201204-80148339-CBBC-4715-BC37-3A25D78571A4Q24244383-39271398-4CDC-4431-B7FA-2C6AF1EA6295Q24795485-EAB95A45-3BC3-4DBA-8D74-8E84E5356987Q27691377-6FA14963-3C4C-4C63-92FC-39A9ED3939FBQ30657638-C0150740-EF46-4511-9742-1CF890CB3F42Q34179621-8255C9CF-F1DC-4306-B2D0-0D293852AC24Q35226555-582F47AC-C007-4C97-A176-3BF0E7719D60Q35743715-21DAA040-19DE-4243-9132-7F462D221272Q36258865-5B7442A1-747C-47CA-BAB0-852A1AC4B1D6Q36899783-40211ED3-0978-475D-A0A1-32CFE96695CAQ37422349-F86A1CA7-F890-47B3-A3B2-D31D0DF940D3Q37683800-3B0677BD-9E47-4CB4-9EDB-4F2F39293008Q37890483-C55597F4-2A23-4C55-87AF-BBEFDECF600BQ37957299-8F9277EA-405B-4328-B86A-A3F1A7269CA2Q38103936-2E5ADE3D-9041-44BA-BE98-5E3DF5489D25Q38107270-CD55E639-6AFC-4CF0-B770-6B9A386D3761Q38394059-45D3AE43-F4B3-4632-B9D5-CD9A46E10B73Q38599413-6FBE78B2-E19C-4722-9FD2-702AE4FF08D3Q38649988-B0D5B4DA-ACFA-4F96-9294-D1093813E102Q38674403-02D46659-2744-4AFC-BDD3-AA5017B3F013Q38718781-207CC32B-A8F8-41D1-9173-82C627B8E93FQ39227811-64F1FFBF-3D85-43F0-A6B1-6C5DB3111A12Q39695891-36058520-0519-4082-B3C5-AE47564EEB23Q40382416-0777EA86-FB1E-4E66-B950-A56426C6DC4DQ40518174-2731B3F7-7B5C-4A1A-B6D9-DD3C32A2FCC0Q40613218-9C895692-1E84-4775-981D-7F95396DEBA6Q40897896-E46728B1-D96B-4BAC-9053-C708177C6074Q40914137-F8C0163F-13C6-4D9B-BB11-BDAAA6008D6AQ41110431-CF3FAA54-9563-41E2-A6CD-1B22162C6E44Q41641512-783CB6FF-5308-4A8F-A47F-2FE665737F0EQ42608053-8C0BC596-A491-4398-BA90-DD5835E3B30CQ43089992-29FDF67C-A615-4CCD-8DDE-98CDB1F01CFCQ43928420-08A78005-F6A7-4587-BACE-F42B062DAB0BQ44754709-04450AF4-3427-4FA3-A597-6FC1DD4CF9A6Q46710832-040B4BF8-E1D4-4F4C-8AB7-F505647DFE68Q47235881-CB51FDE3-FFEB-4841-B77E-CE638841206BQ47354231-8D58D25F-CE4C-4B2D-9EF0-F68BCD21FEDAQ47424936-67B664CF-9EC0-4A3D-91EF-F77984635DEDQ47616404-AE8AFD37-89BF-467D-95A1-25C143629088Q47624933-FA7F4045-B72A-49B6-95FF-62A5E6275FE1
P2860
Quality of life and disease severity are correlated in children with atopic dermatitis
description
im Februar 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 2004
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2004
@uk
name
Quality of life and disease severity are correlated in children with atopic dermatitis
@en
Quality of life and disease severity are correlated in children with atopic dermatitis
@nl
type
label
Quality of life and disease severity are correlated in children with atopic dermatitis
@en
Quality of life and disease severity are correlated in children with atopic dermatitis
@nl
prefLabel
Quality of life and disease severity are correlated in children with atopic dermatitis
@en
Quality of life and disease severity are correlated in children with atopic dermatitis
@nl
P2860
P1476
Quality of life and disease severity are correlated in children with atopic dermatitis
@en
P2093
M A Ben-Gashir
P2860
P304
P356
10.1111/J.1365-2133.2004.05776.X
P407
P50
P577
2004-02-01T00:00:00Z